Serum IGFBP‐3 levels in CRC were lower than those of controls (4.68 [3.56, 5.77] vs 5.44 [4.77, 6.10] μg/mL, P < 0.05). The gene discussed is IGFBP3; the disease is colorectal carcinoma.